Bispecific antibodies in cancer therapy

Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma.

Oncogene·2016

Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion.

Oncogene·2016

Acquisition of estrogen independence induces TOB1-related mechanisms supporting breast cancer cell proliferation.

Oncogene·2015

Mechanisms of action of therapeutic antibodies for cancer.

Molecular immunology·2015

Synthetic lethal screening reveals FGFR as one of the combinatorial targets to overcome resistance to Met-targeted therapy.

Oncogene·2014

Dual inhibition of SRC and Aurora kinases induces postmitotic attachment defects and cell death.

Oncogene·2011

Basic and Translational Research Advances in NSCLC.

Cancer journal (Sudbury, Mass.)·2026

Medical Management of Non-Small Cell Lung Cancer Brain Metastases in the Modern Era.

Cancer journal (Sudbury, Mass.)·2026

Optimizing the Care of Patients With Locally Advanced NSCLC With Multimodality Therapy.

Cancer journal (Sudbury, Mass.)·2026

Early-Stage NSCLC: Novel Surgical Techniques and Neoadjuvant, Adjuvant, and Perioperative Therapies.

Cancer journal (Sudbury, Mass.)·2026

Lung Cancer Biomarker Testing: IHC, Tissue Genomics, Digital Pathology, and ctDNA.

Cancer journal (Sudbury, Mass.)·2026

The Quest to Cure Metastatic Non-Small Cell Lung Cancer With Immunotherapy.

Cancer journal (Sudbury, Mass.)·2026

Allogeneic stem cell transplantation after myeloablative conditioning with fludarabine, thiotepa, and cyclophosphamide in relapsed or refractory aggressive B-cell and T-cell lymphomas: results of the prospective ASTRAL study.

Haematologica·2026

Prior anti-BCMA antibody-drug conjugate exposure does not impact long-term outcomes with subsequent anti-BCMA T-cell-engaging bispecific antibodies: a singlecenter real-world data analysis.

Haematologica·2026

IVIG-associated anterior uveitis resolving after switch to subcutaneous immunoglobulin.

Immunotherapy advances·2026

Related Experiment Videos

Bispecific antibodies in cancer therapy

Related Concept Videos

Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma.

Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion.

Acquisition of estrogen independence induces TOB1-related mechanisms supporting breast cancer cell proliferation.

Mechanisms of action of therapeutic antibodies for cancer.

Synthetic lethal screening reveals FGFR as one of the combinatorial targets to overcome resistance to Met-targeted therapy.

Dual inhibition of SRC and Aurora kinases induces postmitotic attachment defects and cell death.

Basic and Translational Research Advances in NSCLC.

Medical Management of Non-Small Cell Lung Cancer Brain Metastases in the Modern Era.

Optimizing the Care of Patients With Locally Advanced NSCLC With Multimodality Therapy.

Early-Stage NSCLC: Novel Surgical Techniques and Neoadjuvant, Adjuvant, and Perioperative Therapies.

Lung Cancer Biomarker Testing: IHC, Tissue Genomics, Digital Pathology, and ctDNA.

The Quest to Cure Metastatic Non-Small Cell Lung Cancer With Immunotherapy.

Allogeneic stem cell transplantation after myeloablative conditioning with fludarabine, thiotepa, and cyclophosphamide in relapsed or refractory aggressive B-cell and T-cell lymphomas: results of the prospective ASTRAL study.

Prior anti-BCMA antibody-drug conjugate exposure does not impact long-term outcomes with subsequent anti-BCMA T-cell-engaging bispecific antibodies: a singlecenter real-world data analysis.

IVIG-associated anterior uveitis resolving after switch to subcutaneous immunoglobulin.

Related Experiment Videos

Bispecific antibodies in cancer therapy

Related Concept Videos

Related Articles